Goldenwell Biotech, Inc. (GWLL)
OQB · Consumer Defensive · Packaged Foods
$0.70
+0.00%
Closing price as of 2026-09-10 · Source: TEK2day Finance
Key Metrics
Market Cap
$69.3M
Shares Outstanding
99.0M
P/S (TTM)
2,766x
Exchange
OQB
Currency
USD
About Goldenwell Biotech, Inc.
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Hudson, Ohio.
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 25K | 55.00 | 0.00 | 0.00 |
| Gross Profit | 25K | 12.00 | 0.00 | 0.00 |
| Operating Income | (6K) | (23K) | (31K) | (35K) |
| Net Income | (8K) | (200K) | (18K) | (37K) |
| Diluted EPS | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 48K | 2K | 139.00 | 55.00 |
| Gross Profit | 25K | 666.00 | 64.00 | 12.00 |
| Operating Income | (985K) | (116K) | (123K) | (113K) |
| Net Income | (985K) | (117K) | (131K) | (296K) |
| Diluted EPS | $-0.01 | $0.00 | $0.00 | $-0.00 |